Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 29% ± 13% | |
GABAergic neuron | 6 studies | 34% ± 16% | |
glutamatergic neuron | 6 studies | 33% ± 13% | |
oligodendrocyte | 6 studies | 30% ± 9% | |
neuron | 5 studies | 36% ± 17% | |
interneuron | 5 studies | 49% ± 24% | |
macrophage | 5 studies | 28% ± 8% | |
epithelial cell | 5 studies | 28% ± 11% | |
ciliated cell | 5 studies | 20% ± 5% | |
basal cell | 4 studies | 30% ± 12% | |
astrocyte | 4 studies | 30% ± 12% | |
granule cell | 3 studies | 22% ± 4% | |
microglial cell | 3 studies | 27% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 9% | |
T cell | 3 studies | 18% ± 2% | |
lymphocyte | 3 studies | 23% ± 5% | |
goblet cell | 3 studies | 29% ± 14% | |
transit amplifying cell | 3 studies | 34% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 32% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2807.25 | 1445 / 1445 | 100% | 47.26 | 183 / 183 |
stomach | 100% | 1725.53 | 359 / 359 | 100% | 36.77 | 285 / 286 |
intestine | 100% | 2476.88 | 966 / 966 | 100% | 32.86 | 525 / 527 |
breast | 100% | 2301.07 | 459 / 459 | 100% | 29.47 | 1113 / 1118 |
thymus | 100% | 3021.54 | 653 / 653 | 100% | 27.65 | 602 / 605 |
prostate | 100% | 2216.99 | 245 / 245 | 99% | 19.68 | 499 / 502 |
bladder | 100% | 2200.14 | 21 / 21 | 99% | 24.74 | 500 / 504 |
lung | 100% | 2169.32 | 578 / 578 | 99% | 32.30 | 1145 / 1155 |
uterus | 100% | 2625.96 | 170 / 170 | 99% | 28.32 | 455 / 459 |
skin | 100% | 3428.16 | 1809 / 1809 | 99% | 27.50 | 467 / 472 |
pancreas | 99% | 1184.96 | 326 / 328 | 99% | 21.15 | 176 / 178 |
kidney | 100% | 1895.61 | 89 / 89 | 97% | 18.04 | 878 / 901 |
ovary | 100% | 2152.41 | 180 / 180 | 96% | 19.30 | 413 / 430 |
brain | 99% | 2053.95 | 2612 / 2642 | 97% | 16.29 | 683 / 705 |
liver | 100% | 1113.61 | 226 / 226 | 88% | 12.51 | 358 / 406 |
adrenal gland | 100% | 1756.56 | 258 / 258 | 87% | 12.69 | 200 / 230 |
adipose | 100% | 1975.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1898.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.59 | 29 / 29 |
spleen | 100% | 2077.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 42.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.64 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 98% | 14.51 | 78 / 80 |
muscle | 97% | 968.76 | 776 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2198.80 | 888 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 861.77 | 795 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | TCF20 |
Protein name | Transcription factor 20 Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein) |
Synonyms | hCG_41553 SPBP KIAA0292 |
Description | FUNCTION: Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator. . |
Accessions | ENST00000683686.1 [Q9UGU0-1] ENST00000404876.1 ENST00000515426.1 ENST00000677622.1 [Q9UGU0-1] ENST00000574164.2 A0A6Q8PH68 ENST00000627133.1 ENST00000576946.5 [Q9UGU0-2] A9JX13 ENST00000630841.1 ENST00000574269.1 W5ZR30 ENST00000359486.8 [Q9UGU0-1] ENST00000335626.8 [Q9UGU0-2] ENST00000619505.3 [Q9UGU0-2] Q9UGU0 ENST00000574943.5 [Q9UGU0-1] ENST00000621408.4 [Q9UGU0-1] ENST00000675876.1 I3L1M7 |